Alto Neuroscience, Inc. (ANRO) Misses Q3 EPS by 6c

Alto Neuroscience, Inc. (NYSE: ANRO) reported Q3 EPS of ($0.62), $0.06 worse than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters
• Independence Realty Trust (IRT) files mixed shelf